Filing step-change
OXYGENTAPH · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-20 · Evidence medium
Oxygenataph (OXYGENTAPH) Sees Accelerating Gross Margin and Marginal Operating Leverage, Despite Declining Daily Volume and Close Price.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 13.1 % | -0.19 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -0.19 % | -10.04 | ▲ |
Cite this
Source: Samhati filing step-change for OXYGENTAPH (2026-10). Observation: Oxygenataph (OXYGENTAPH) Sees Accelerating Gross Margin and Marginal Operating Leverage, Despite Declining Daily Volume and Close Price. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/oxygentaph/q/2026-10
Other periods